Royal Fund Management LLC Grows Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Royal Fund Management LLC increased its stake in Omega Healthcare Investors, Inc. (NYSE:OHIFree Report) by 87.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 60,734 shares of the real estate investment trust’s stock after buying an additional 28,329 shares during the period. Royal Fund Management LLC’s holdings in Omega Healthcare Investors were worth $2,473,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Cutter & CO Brokerage Inc. increased its position in shares of Omega Healthcare Investors by 3.7% in the 2nd quarter. Cutter & CO Brokerage Inc. now owns 8,206 shares of the real estate investment trust’s stock worth $281,000 after purchasing an additional 290 shares during the last quarter. NCP Inc. increased its holdings in Omega Healthcare Investors by 10.3% in the second quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust’s stock valued at $113,000 after buying an additional 310 shares during the last quarter. Left Brain Wealth Management LLC increased its holdings in Omega Healthcare Investors by 2.0% in the fourth quarter. Left Brain Wealth Management LLC now owns 17,365 shares of the real estate investment trust’s stock valued at $532,000 after buying an additional 335 shares during the last quarter. Pasadena Private Wealth LLC raised its stake in Omega Healthcare Investors by 2.9% during the second quarter. Pasadena Private Wealth LLC now owns 12,049 shares of the real estate investment trust’s stock valued at $413,000 after buying an additional 335 shares in the last quarter. Finally, Bay Colony Advisory Group Inc d b a Bay Colony Advisors grew its position in shares of Omega Healthcare Investors by 4.7% in the 2nd quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 7,574 shares of the real estate investment trust’s stock worth $259,000 after acquiring an additional 342 shares in the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on OHI shares. Scotiabank upped their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th. Wells Fargo & Company reissued an “overweight” rating and set a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Truist Financial lifted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price objective for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Finally, BMO Capital Markets raised their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a report on Monday. Eight analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $37.00.

Get Our Latest Report on Omega Healthcare Investors

Insider Buying and Selling at Omega Healthcare Investors

In related news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at $4,025,000. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Omega Healthcare Investors Stock Performance

NYSE OHI traded up $0.10 on Wednesday, hitting $39.61. The stock had a trading volume of 38,588 shares, compared to its average volume of 1,671,823. The company’s 50-day moving average is $39.16 and its two-hundred day moving average is $34.72. The stock has a market cap of $9.79 billion, a price-to-earnings ratio of 35.59, a P/E/G ratio of 1.29 and a beta of 1.00. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $41.53.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last posted its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The business had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. During the same quarter in the prior year, the business earned $0.74 earnings per share. The firm’s revenue was up 17.5% compared to the same quarter last year. On average, analysts expect that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Monday, August 5th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.77%. The ex-dividend date of this dividend was Monday, August 5th. Omega Healthcare Investors’s payout ratio is currently 241.44%.

Omega Healthcare Investors Company Profile

(Free Report)

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

Recommended Stories

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHIFree Report).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.